These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2568845)

  • 21. Human complement C3b/C4b receptor (CR1) mRNA polymorphism that correlates with the CR1 allelic molecular weight polymorphism.
    Holers VM; Chaplin DD; Leykam JF; Gruner BA; Kumar V; Atkinson JP
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2459-63. PubMed ID: 3031685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythrocyte CR1 expression level does not correlate with a HindIII restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility.
    Rowe JA; Raza A; Diallo DA; Baby M; Poudiougo B; Coulibaly D; Cockburn IA; Middleton J; Lyke KE; Plowe CV; Doumbo OK; Moulds JM
    Genes Immun; 2002 Dec; 3(8):497-500. PubMed ID: 12486610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Association between genetic polymorphism of erythrocyte CR1 and the susceptibility of idiopathic pulmonary fibrosis].
    Yuan YD; Zhao MX; Yu J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Nov; 34(11):841-5. PubMed ID: 22333472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus.
    Moldenhauer F; David J; Fielder AH; Lachmann PJ; Walport MJ
    Arthritis Rheum; 1987 Sep; 30(9):961-6. PubMed ID: 2959289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.
    Mahmoudi R; Feldman S; Kisserli A; Duret V; Tabary T; Bertholon LA; Badr S; Nonnonhou V; Cesar A; Neuraz A; Novella JL; Cohen JHM
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30044434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative variations of the C3b/C4b receptor (CR1) in human erythrocytes are controlled by genes within the regulator of complement activation (RCA) gene cluster.
    Rodriguez de Cordoba S; Rubinstein P
    J Exp Med; 1986 Oct; 164(4):1274-83. PubMed ID: 2944984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of the HindIII restriction fragment length polymorphism among patients with systemic lupus erythematosus with different concentrations of CR1.
    Satoh H; Yokota E; Tokiyama K; Kawaguchi T; Niho Y
    Ann Rheum Dis; 1991 Nov; 50(11):765-8. PubMed ID: 1685310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low erythrocyte complement receptor type 1 (CR1, CD35) expression in preeclamptic gestations.
    Feinberg BB; Jack RM; Mok SC; Anderson DJ
    Am J Reprod Immunol; 2005 Dec; 54(6):352-7. PubMed ID: 16305660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
    Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
    Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decay-accelerating factor. Genetic polymorphism and linkage to the RCA (regulator of complement activation) gene cluster in humans.
    Rey-Campos J; Rubinstein P; Rodriguez de Cordoba S
    J Exp Med; 1987 Jul; 166(1):246-52. PubMed ID: 2439634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematologic correlates and the role of erythrocyte CR1 (C3b receptor) in the development of AIDS.
    Inada Y; Lange M; McKinley GF; Sonnabend JA; Fonville TW; Kanemitsu T; Tanaka M; Clark WS
    AIDS Res; 1986; 2(3):235-47. PubMed ID: 2944517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired loss of erythrocyte complement receptor type 1 in patients with diabetic nephropathy undergoing hemodialysis.
    Wakabayashi M; Ohi H; Tamano M; Onda K; Fujita T; Tomino Y
    Nephron Exp Nephrol; 2006; 104(3):e89-95. PubMed ID: 16837818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.
    Wong WW; Cahill JM; Rosen MD; Kennedy CA; Bonaccio ET; Morris MJ; Wilson JG; Klickstein LB; Fearon DT
    J Exp Med; 1989 Mar; 169(3):847-63. PubMed ID: 2564414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
    Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
    Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
    Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
    Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human complement receptors for C3b (CR1) and C3d (CR2).
    Fearon DT
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):53s-57s. PubMed ID: 2989379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome.
    Tausk FA; McCutchan A; Spechko P; Schreiber RD; Gigli I
    J Clin Invest; 1986 Oct; 78(4):977-82. PubMed ID: 2944915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
    Moldenhauer F; Botto M; Walport MJ
    Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of complement receptor 1 on erythrocytes: follow-up of HIV-1-infected patients with AIDS-related complex/Walter-Reed 5 under treatment with intravenous immunoglobulin. The ARC-IVIG Study Group.
    Spycher MO; Späth PJ
    Vox Sang; 1990; 59 Suppl 1():44-50. PubMed ID: 2146812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired but reversible loss of erythrocyte complement receptor 1 (CR1, CD35) and its longitudinal alteration in patients with severe acute respiratory syndrome.
    Wang FS; Chu FL; Jin L; Li YG; Zhang Z; Xu D; Shi M; Wu H; Moulds JM
    Clin Exp Immunol; 2005 Jan; 139(1):112-9. PubMed ID: 15606620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.